Join
Live feed
·
INSIDERFilingvia Quantisnow
Chinook Therapeutics Inc. logo

SEC Form 4: Frohlich Tom converted options into 8,333 shares and sold $112,700 worth of shares (4,566 units at $24.68), increasing direct ownership by 3% to 147,674 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KDNY (Chinook Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Frohlich Tom converted options into 8,333 shares and sold $112,700 worth of shares (4,566 units at $24.68), increasing direct ownership by 3% to 147,674 units (for tax liability) | Quantisnow